These innovative medications , Retatrutide, represent a groundbreaking advancement in managing metabolic dysfunction and potentially other ailments . They are grouped as GLP-1 receptor agonists , https://ianueip873706.blogaritma.com/39299564/semaglutide-a-comprehensive-dive-into-incretin-agents